The association between MMP-12 82 A/G polymorphism and susceptibility to various malignant tumors: a meta-analysis

Sheng-Song Chen1, Juan Song1, Xiao-Yun Tu1

  • 1Department of Respiratory Diseases, The Second Affiliated Hospital of Nanchang University Nanchang 330006, China.

Insights

The MMP-12 82 A/G polymorphism is not linked to overall cancer risk. However, the G allele of this single nucleotide polymorphism (SNP) increases susceptibility to epithelial ovarian carcinoma (EOC).

Area of Science:

  • Genetics
  • Oncology
  • Molecular Biology

Background:

  • Matrix metalloproteinases (MMPs) degrade extracellular matrix components.
  • MMPs are implicated in tumor growth, invasion, and metastasis.
  • The MMP-12 82 A/G (rs2276109) single nucleotide polymorphism (SNP) influences MMP-12 expression, but its link to cancer susceptibility is debated.

Purpose of the Study:

  • To investigate the association between the MMP-12 82 A/G polymorphism and susceptibility to nine types of malignant tumors.
  • To clarify the controversial role of this specific MMP-12 SNP in cancer development.

Main Methods:

  • A meta-analysis was conducted on 11 studies.
  • Data from 6153 cancer patients and 6838 controls were analyzed.
  • Two independent reviewers screened studies and extracted relevant data.

Main Results:

  • No overall association was found between the MMP-12 82 A/G polymorphism and susceptibility to the nine studied tumors.
  • Subgroup analysis revealed the G allele significantly increases susceptibility to epithelial ovarian carcinoma (EOC).
  • The G allele showed increased risk in both allele (OR=2.45) and dominant (OR=2.52) models for EOC.

Conclusions:

  • The MMP-12 82 A/G polymorphism does not appear to be a general risk factor for the nine common cancers studied.
  • The G allele of the MMP-12 82 A/G polymorphism is identified as a specific genetic risk factor for epithelial ovarian carcinoma (EOC).